Rhythm announced today the results of two Phase 1 clinical trials of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis, which demonstrated that RM-131 greatly accelerates gastric emptying in healthy subjects with good tolerability.
URL: http://www.news-medical.net/news/20121022/Rhythm-presents-RM-131-Phase-1-clinical-trial-results-for-diabetic-gastroparesis-at-ACG-2012.aspx
No comments:
Post a Comment